NovaBridge Biosciences (NBP) stock
NBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 0/30
$0.82+0.03 (+3.89%)
Close on Nov 17, 2026Market cap $94.88MP/E –Yield –
NovaBridge Biosciences gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2021 it was 47.3%, against 100.0% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | 47.3% | −52.7 |
| FY2020 | Dec 31, 2020 | 100.0% | +0.0 |
| FY2019 | Dec 31, 2019 | 100.0% | – |
See a number that looks wrong?